431 related articles for article (PubMed ID: 19013242)
1. Network biomarkers for the diagnosis and treatment of movement disorders.
Poston KL; Eidelberg D
Neurobiol Dis; 2009 Aug; 35(2):141-7. PubMed ID: 19013242
[TBL] [Abstract][Full Text] [Related]
2. Abnormal metabolic brain networks in Parkinson's disease from blackboard to bedside.
Tang CC; Eidelberg D
Prog Brain Res; 2010; 184():161-76. PubMed ID: 20887874
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical anatomy of movement disorders.
Young AB; Penney JB
Neurol Clin; 1984 Aug; 2(3):417-33. PubMed ID: 6152481
[TBL] [Abstract][Full Text] [Related]
4. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).
Marsden CD
Mod Trends Neurol; 1975; 6():141-66. PubMed ID: 127927
[No Abstract] [Full Text] [Related]
5. Biomarkers in Huntington's and Parkinson's Disease.
O'Keeffe GC; Michell AW; Barker RA
Ann N Y Acad Sci; 2009 Oct; 1180():97-110. PubMed ID: 19906264
[TBL] [Abstract][Full Text] [Related]
6. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
Nicoletti G; Tonon C; Lodi R; Condino F; Manners D; Malucelli E; Morelli M; Novellino F; Paglionico S; Lanza P; Messina D; Barone P; Morgante L; Zappia M; Barbiroli B; Quattrone A
Mov Disord; 2008 Dec; 23(16):2370-6. PubMed ID: 18816803
[TBL] [Abstract][Full Text] [Related]
7. Involuntary movement disorders.
Still CN
Neurol Clin; 1984 Feb; 2(1):71-89. PubMed ID: 6239089
[TBL] [Abstract][Full Text] [Related]
8. [Specific therapy of extrapyramidal-motor syndromes].
Hartmann-von Monakow K
Bibl Psychiatr Neurol; 1969; 139():705-11. PubMed ID: 4257724
[No Abstract] [Full Text] [Related]
9. [Neuropsychological evaluation can contribute to the diagnosis of movement disorders].
Dubois B; Beato R; Villalpando JM
Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S50-6. PubMed ID: 12773888
[TBL] [Abstract][Full Text] [Related]
10. Catecholamines and neurologic diseases (second of two parts).
Moskowitz MA; Wurtman RJ
N Engl J Med; 1975 Aug; 293(7):332-8. PubMed ID: 125386
[No Abstract] [Full Text] [Related]
11. Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progression.
Marek K; Jennings D; Tamagnan G; Seibyl J
Ann Neurol; 2008 Dec; 64 Suppl 2():S111-21. PubMed ID: 19127587
[TBL] [Abstract][Full Text] [Related]
12. Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders.
Constantinescu R; Zetterberg H; Holmberg B; Rosengren L
Parkinsonism Relat Disord; 2009 Mar; 15(3):205-12. PubMed ID: 18562238
[TBL] [Abstract][Full Text] [Related]
13. Looking backward to move forward: early detection of neurodegenerative disorders.
DeKosky ST; Marek K
Science; 2003 Oct; 302(5646):830-4. PubMed ID: 14593169
[TBL] [Abstract][Full Text] [Related]
14. [Surgical treatment of movement disorders].
Massager N
Rev Med Brux; 2008 Sep; 29(4):248-51. PubMed ID: 18949972
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the progression of Parkinson's disease: a metabolic network approach.
Eckert T; Tang C; Eidelberg D
Lancet Neurol; 2007 Oct; 6(10):926-32. PubMed ID: 17884682
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of neurodegenerative disorders: how good are they?
Rachakonda V; Pan TH; LE WD
Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation.
Chinnery PF; Crompton DE; Birchall D; Jackson MJ; Coulthard A; Lombès A; Quinn N; Wills A; Fletcher N; Mottershead JP; Cooper P; Kellett M; Bates D; Burn J
Brain; 2007 Jan; 130(Pt 1):110-9. PubMed ID: 17142829
[TBL] [Abstract][Full Text] [Related]
18. Neurochemical biomarkers in the differential diagnosis of movement disorders.
Mollenhauer B; Trenkwalder C
Mov Disord; 2009 Jul; 24(10):1411-26. PubMed ID: 19412961
[TBL] [Abstract][Full Text] [Related]
19. Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease.
Hirano S; Eckert T; Flanagan T; Eidelberg D
Mov Disord; 2009; 24 Suppl 2(0 2):S725-31. PubMed ID: 19877247
[TBL] [Abstract][Full Text] [Related]
20. Can we image premotor Parkinson disease?
Marek K; Jennings D
Neurology; 2009 Feb; 72(7 Suppl):S21-6. PubMed ID: 19221310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
